Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib

被引:7
作者
Cervetti, G
Galimberti, S
Fazzi, R
Papineschi, F
Azzarà, A
Simi, P
Petrini, M
机构
[1] Univ Pisa, Dept Oncol, Div Hematol, Pisa, Italy
[2] Univ Pisa, Dept Pediat, UO Cytogenet & Mol Genet, Pisa, Italy
关键词
D O I
10.1111/j.1365-2362.2004.01310.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:243 / 244
页数:2
相关论文
共 4 条
[1]   Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].
Bumm, T ;
Müller, C ;
Al-Ali, HK ;
Krohn, K ;
Shepherd, P ;
Schmidt, E ;
Leiblein, S ;
Franke, C ;
Hennig, E ;
Friedrich, T ;
Krahl, R ;
Niederwieser, D ;
Deininger, MWN .
BLOOD, 2003, 101 (05) :1941-1949
[2]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[3]   The emergence of Ph-, trisomy-8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate [J].
Feldman, E ;
Najfeld, V ;
Schuster, M ;
Roboz, G ;
Chadburn, A ;
Silver, RT .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (08) :702-707
[4]  
Mitelman F., 1994, CATALOG CHROMOSOME A